Intravenous BI 6727 (Volasertib) in 2nd Line Treatment of Urothelial Cancer
Clinical trial NCT01023958 · COMPLETED
Trial details
- NCT number
- NCT01023958
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-11-19
- Primary completion
- 2011-09-19
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.